-
-
-
-
-
-
- The "New" Prostate Cancer InfoLink has been developed to become a primary source of accurate, current, and topical information about prostate cancer for patients and their families.
A service of
Awards
Other PCI web sites
One Response
Leave a Reply
This site uses Akismet to reduce spam. Learn how your comment data is processed.
-
Disclaimer
News and information provided on this site should not be used for diagnosing or treating any health problem or disease.
The “New” Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services and is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.
-
Hot Posts …
- Active surveillance: a future perspective
- NCCN guidance on initial management of low-risk, localized prostate cancer (redux)
- Projected attendance at AS research conference
- Registration for major active surveillance (AS) research conference now open
- NCCN guidance on the initial management of low-risk, localized prostate cancer
- Exceptions to “early salvage” radiation treatment for recurrence after prostatectomy
- Chances to hear from the new President and CEO of the Prostate Cancer Foundation
- More than 25 organizations join new Prostate Cancer Impact Alliance
- Educational opportunities on September 29 upcoming
- Whole-pelvic radiation therapy for high-risk patients
- Fear of prostate cancer recurrence post-surgery
- Timing of initiation of ADT for men with biochemical progression after first-line surgery
- Rethinking risk stratification for radiation therapy
- AS research survey: your help still needed
- Helpful upcoming webinars this week
… and Archives
Blog at WordPress.com. WP Designer.
THE "NEW" PROSTATE CANCER INFOLINK 
So how do we change the conversation? If these statistics are outdated, what are the updated survival rates? Is it too early to tell because new treatments haven’t been around long enough? It seems like every drug or therapy I’ve seen adds 3 to 4 months to survival presumably compared to doing nothing. So if we use these new HT drugs, chemo, RT and immunotherapy, are they additive in terms of additional survival? The implication here is that if we just follow “standard of treatment ” we’ll only have 2 to 4 years of remaining life after we become castrate resistant and have distant metastases. So we need to take things into our own hands and be more aggressive if we want longer survival. How does one do that? Must we seek out doctors willing to go beyond the bounds of “standard treatments”?